Category Archives: Biostatistics and Evaluation

New study finds heart failure readmission associated with poorer long-term outcomes and cost for Medicare patients

By | November 1, 2016

In a study of more than 7500 Medicare beneficiaries hospitalized for heart failure in 1998-2001, 30-day all-cause readmission was associated with a higher risk of subsequent all-cause mortality, higher number of cumulative all-cause readmission, longer cumulative length of stay, and higher cumulative cost. Published this month in the American Journal of Medicine. the study, led by researchers at the Veterans Affairs Medical Center of Washington, DC, was co-authored by Dr. Thomas Love, director of Biostatistics and Evaluation for the Center for Health Care Research and Policy…

Study finds no strong link between spironolactone therapy and readmission for heart failure in patients with reduced ejection fraction

By | November 1, 2016

A discharge prescription for spironolactone had no association with 30-day all-cause readmission among older, hospitalized Medicare beneficiaries with heart failure and reduced ejection fraction who were eligible for spironolactone therapy. The study, published this month by the International Journal of Cardiology, was led by researchers at Georgetown University and the VA Medical Center of Washington DC, and co-authored by Dr. Thomas Love, Director of Biostatistics and Evaluation at the Center for Health Care Research and Policy…

Research Linking Neighborhood Deprivation to Increased Cardiovascular Risk Earns International Recognition

By | October 22, 2016

“Neighborhood Socioeconomic Status and Major Atherosclerotic Event Rates: An Analysis of Geocoded Electronic Health Data” identifies substantial geographic variation in various socioeconomic measures related to risk for and prevention of atherosclerotic cardiovascular disease. Researchers including Jarrod Dalton, Adam Perzynski, and Neal Dawson, in collaboration with experts in health policy, internal medicine, and social work presented their work at a “Top-Rated Abstracts” session of the Society for Medical Decision Making Meeting in Vancouver, Canada…